Markets.com Logo
markets.com

IFRX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

IFRX.US represents InflaRx N.V., a clinical-stage biopharmaceutical company headquartered in Jena, Germany. InflaRx is focused on discovering and developing novel therapeutics targeting the complement system, specifically C5a, to treat a variety of inflammatory and autoimmune diseases. Their lead product candidate, vilobelimab (IFX-1), is a first-in-class monoclonal anti-C5a antibody and is currently in clinical development for various indications, including critical COVID-19 and other complement-mediated diseases. The company's shares are listed on the Nasdaq Global Select Market under the ticker symbol IFRX.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

Company Performance: IFRX.US's revenue, earnings, and profitability directly influence investor confidence. Strong financial results typically drive the stock price upward.

Industry Trends: The overall health and growth prospects of the biotechnology industry impact IFRX.US. Positive industry trends often benefit companies within that sector.

Regulatory Approval: Approval of IFRX.US's products by regulatory bodies like the FDA is a crucial catalyst for stock price increases. Delays or rejections can negatively affect the stock.

Clinical Trial Results: Data from IFRX.US's clinical trials significantly affects investor sentiment. Positive results indicating drug efficacy can boost the stock; negative outcomes can depress it.

Market Sentiment: General market conditions and investor risk appetite influence IFRX.US. Bull markets often lift stocks, while bear markets exert downward pressure.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com